Phase IIIB,randomized open-label study of pegylated interferon alfa-2a in combination with lamivudine or entacavir comapred with untreated control patients in children with HBeAg positive chronic hepatitis B in the immune tolereant phase | AVESİS

Ankara Üniversitesi Akademik Veri Yönetim Sistemi

Phase IIIB,randomized open-label study of pegylated interferon alfa-2a in combination with lamivudine or entacavir comapred with untreated control patients in children with HBeAg positive chronic hepatitis B in the immune tolereant phase

Diğer Uluslararası Fon Programları, 2015 - 2018

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Ocak 2015
Bitiş Tarihi: Mart 2018